Evaluation of efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity) - A pilot study
DOI:
https://doi.org/10.47552/ijam.v15i2.4587Keywords:
Amlapitta, Avipattikar churna, Chitrakadi kwath, Hyperacidity, Mandagni, TiktamlaudgarAbstract
Amlapitta is a condition characterised by the predominance of Pitta and is associated with the Annavaha and Purishvaha srotas. It manifests as a result of imbalances in Mandagni (weakened digestive fire) and the presence of Ama (undigested or improperly metabolized substances). The prevalence rate of Amlapitta in India is 38.1%. Considering the similarities in etiopathogenesis, it can be correlated with Hyperacidity in Modern Science. Aim and Objectives: To evaluate the efficacy of Avipattikar churna versus Chitrakadi kwath in the management of Amlapitta (Hyperacidity). Methodology: An Interventional Study was conducted among 30 patients between the ages of 20 and 60 of either sex who had symptoms of Tikta Amlodgar (sour and bitter irructation), Hrit-kanthadaha (burning in heart and throat), Udarashool (epigastric pain) and Utklesha (nausea), and Aruchi (anorexia). Group A was given Aipattikar Churna; Group B was given Chitrakadi Kwath. Subjective Parameters were assessed in both groups on the 0th, 7th, and 15th days, and comparison was done by statistical analysis. Observation and Discussion: Both interventions proved effective, showcasing strengths in addressing distinct subjective parameters. Conclusion: Both drugs demonstrated high effectiveness in the study. Group A exhibited significant improvements across all subjective parameters, except Udarshoola (Abdominal pain). On the other hand, Group B displayed notable results in all subjective parameters, except for Utklesha and Aruchi. In conclusion, both groups were significant.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.